Soluble monocyte cluster domain 163, a new global marker of anti-inflammatory response, is elevated in the first trimester of pregnancy [2]

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 6, 2004, Pages 1009-1010

  Paidas, Michael J ^a   Ku, D H W ^a   Davis, B ^b   Lockwood, C J ^a   Arkel, Y S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Maine Medical Center Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; SCAVENGER RECEPTOR;

ADULT; ANTIINFLAMMATORY ACTIVITY; BLASTOCYST; BLOOD SAMPLING; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVIDENCE BASED MEDICINE; FEMALE; FERTILIZATION; FIRST TRIMESTER PREGNANCY; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; LETTER; MAJOR CLINICAL STUDY; MONOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; TH2 CELL;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNITY; INFLAMMATION; MALE; MIDDLE AGED; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RECEPTORS, CELL SURFACE; REFERENCE VALUES; SOLUBILITY;

EID: 13244258488     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.00681.x     Document Type: Letter

References (12)

1. Pulford K, Micklem K, McCarthy S, Corrdell J, Jones M, Mason DY, A monocyte/macrophage antigen recognized by the four antibodies GHI/61, Ber-Mac3, Ki-M8 and SM4. Immunology 1992; 75: 588-95.
2. Backe E, Schwarting R, Gerdes J, Ernst M, Stein H. Ber-Mac3: a new monoclonal antibody that defines human monocytes/macrophage differentiation antigen. J Clin Pathol 1991; 44: 936-45.
3. Møller HJ, Hyltoft-Petersen P, Rejnmark L, Moestrup SK. Biological variation of soluble CD163. Scand J Clin Invest 2003; 63: 15-22.
4. Møller HJ, Aerts H, Grønbék H, Peterslund NA, Hyltoft-Petersen P, Hornung N, Rejnmark L, Jabbarpour E, Moestrup SK. Soluble CD163: a marker molecule for monocyte/macrophage activity in disease. Scand J Clin Invest 2002; 237: 29-34.
5. Piccinni MP. Role of immune cells in pregnancy. Autoimmunity 2003; 36: 1-4.
6. Szekeres-Bartho J. Immunological relationship between the mother and the fetus. Int Rev Immunol 2002; 21: 471-95.
7. Kwak-Kim JY, Chung-Bang HS, Ng SC, Ntrivalas EI, Mangubat CP, Beaman KD, Beer AE, Gilman-Sachs A. Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failure after IVF. Hum Reprod 2003; 18: 767-73.
8. Graphou O, Chioti A, Pantazi A, Tsukoura C, Kontopoulou V, Guorgiadou E, Balafoutas C, Koussoulakos S, Margaritis LH, Varla-Leftherioti M. Effect of intravenous immunoglobulin treatment on the Th1/Th2 balance in women with recurrent spontaneous abortions. Am J Reprod Immunol 2003; 49: 21-9.
9. Duc-Goiran P, Mignot TM, Bourgeois C, Ferre F. Embryo-maternal interactions at the implantation site: a delicate equilibrium. Eur J Obstet Gynecol Reprod Biol 1999; 83: 85-100.
10. Runic R, Lockwood CJU, Ma Y, Dipasquale B, Guller S. Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal surviv al. J Clin Endocrinol Metab 1996; 81: 3119-22.
11. Guller S, LaChapelle L. The role of placentation Fas ligand in maintaining immune privilege at maternal-fetal interfaces. Semin Reprod Endocrinal 1999; 17: 39-44.
12. Møller HJ, Hald K, Moestrup SK. Characterization of an enzyme-linked immunosorbent assay for soluble CD163. Scand J Clin Invest 2002; 62: 293-9.